The Sanders Firm is Assigned the First Fosamax Trial
The Sanders Firm is Assigned the First Fosamax Trial The FDA issues another warning concerning the osteoporosis drug Fosamax as The Sanders Firm prepares for the first jury trial against the pharmaceutical giant Merck. Mineola, NY (PRWEB) March 15, 2010 -- The United States Food and Drug Administration, via its website at FDA.gov, has issued a 'FDA Drug Safety Communication' about the common osteoporosis drug Fosamax©, and others of its class, concerning an increased incidence of femur fractures in women. The FDA's statement is part of
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4